434 related articles for article (PubMed ID: 4015285)
21. Cardioselectivity of atenolol and metoprolol. A study in asthmatic patients.
Löfdahl CG; Svedmyr N
Eur J Respir Dis; 1981 Dec; 62(6):396-404. PubMed ID: 6751838
[TBL] [Abstract][Full Text] [Related]
22. Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone.
Dahlöf B; Jönsson L; Borgholst O; Ekblad G; Engstrand C; Grundestam I; Lindh A
Blood Press Suppl; 1993; 1():37-45. PubMed ID: 8173689
[TBL] [Abstract][Full Text] [Related]
23. Double-blind titrated-dose comparison of metoprolol and propranolol in the treatment of angina pectoris.
Frick MH; Luurila O
Ann Clin Res; 1976 Dec; 8(6):385-92. PubMed ID: 795362
[TBL] [Abstract][Full Text] [Related]
24. Sustained release metoprolol: a comparison with conventional formulation in the treatment of hypertension.
Logan RL; Goldstraw PW; Kiddle GB; Flacks LM; Watt M
N Z Med J; 1981 Jul; 93(687):1-2. PubMed ID: 7022275
[TBL] [Abstract][Full Text] [Related]
25. Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension.
Pandhi P; Sahai J; Wahi PL; Sharma BK; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):163-5. PubMed ID: 3549583
[TBL] [Abstract][Full Text] [Related]
26. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
Papademetriou V; Hainer JW; Sugg J; Munzer D;
Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
[TBL] [Abstract][Full Text] [Related]
27. Atenolol or propranolol in hypertensive patients poorly controlled on captopril and frusemide.
Webster J; Petrie JC; Robb OJ; Witte K; Lovell HG
J Hum Hypertens; 1987 Sep; 1(2):121-6. PubMed ID: 3333523
[TBL] [Abstract][Full Text] [Related]
28. The safety and efficacy of once-daily nifedipine coat-core in combination with atenolol in hypertensive patients. Adalat CC Cooperative Study Group.
Mac Carthy EP; Pettis PP; Gibson L; Schwartz L; Feig PU
Clin Ther; 1993; 15(6):976-87. PubMed ID: 8111817
[TBL] [Abstract][Full Text] [Related]
29. Effects of 4 beta-adrenoceptor blocking drugs on blood pressure and exercise heart rate in hypertension.
Harry JD; Knapp MF; Linden RJ; Stoker JB; Newcombe C
Eur J Cardiol; 1979 Aug; 10(2):131-41. PubMed ID: 38965
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the effects of atenolol and propranolol in labile hypertension.
González-Gómez A; Pérez-Medina T; Gamio-Capestany F; Hernández-Cañero A; García-Barreto D
Cor Vasa; 1979; 21(3):202-7. PubMed ID: 535405
[TBL] [Abstract][Full Text] [Related]
31. Atenolol vs. amiloride-hydrochlorothiazide in the treatment of mild to moderate hypertension: a double-blind, crossover, placebo-controlled study.
Lischner M; Lang R; Jutrin I; Ravid M
Drug Intell Clin Pharm; 1987 Jan; 21(1 Pt 1):43-6. PubMed ID: 3545737
[TBL] [Abstract][Full Text] [Related]
32. [Beta-blockaders in the treatment of hypertension in pregnancy].
Kawecka-Jaszcz K; Skoczeń M
Kardiol Pol; 1985; 28(5):334-9. PubMed ID: 2864465
[No Abstract] [Full Text] [Related]
33. Metoprolol and propranolol in the treatment of essential hypertension - a long-term comparative study.
Sjöberg KH
Ann Clin Res; 1981; 13 Suppl 30():23-9. PubMed ID: 7027890
[TBL] [Abstract][Full Text] [Related]
34. Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily.
Olowoyeye JO; Thadani U; Parker JO
Am J Cardiol; 1981 May; 47(5):1123-7. PubMed ID: 7223659
[TBL] [Abstract][Full Text] [Related]
35. A comparative study of the effects of oxprenolol versus propranolol in essential hypertension.
Gavras I; Gavras H; Sullivan PC; Tifft CP; Chobanian AV; Brunner HR
J Clin Pharmacol; 1979 Jan; 19(1):8-14. PubMed ID: 368088
[No Abstract] [Full Text] [Related]
36. Once-daily penbutolol or atenolol can replace combination therapy in essential hypertension.
Houtzagers JJ; Chadha DR
J Int Med Res; 1982; 10(1):1-5. PubMed ID: 7060821
[TBL] [Abstract][Full Text] [Related]
37. [Protection of the hypertensive patient: comparative atenolol-metoprolol study].
Mazzari M; Coppola E; Montenero AS; Schiavoni G; Domenichelli B; Mongiardo R; Pennestrì F
Cardiologia; 1982; 27(8):753-63. PubMed ID: 6892449
[No Abstract] [Full Text] [Related]
38. Studies with long acting propranolol.
Shanks RG
Postgrad Med J; 1984; 60 Suppl 2():61-8. PubMed ID: 6463010
[No Abstract] [Full Text] [Related]
39. Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension.
Dahlöf B; Keller SE; Makris L; Goldberg AI; Sweet CS; Lim NY
Am J Hypertens; 1995 Jun; 8(6):578-83. PubMed ID: 7662242
[TBL] [Abstract][Full Text] [Related]
40. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
